Peptoid and synthetic oligomers, pharmaceutical compositions and methods of
using same
申请人:Sadowski Martin J.
公开号:US20120015883A1
公开(公告)日:2012-01-19
Novel peptide/peptoid oligomers are disclosed that have a formula represented by the following formula Ia or Ib:
The peptide/peptoid oligomers demonstrate the ability to inhibit fibrillization and oligomerization of Aβ and may be prepared as pharmaceutical compositions and used for the prevention or treatment of a variety of conditions in mammals, including humans, associated with Aβ oligomerization. The present peptidomimetic oligomers are particularly valuable for the treatment of subjects with AD.